Alkem Laboratories Limited (NSE:ALKEM)
India
· Delayed Price · Currency is INR 4,782.00
-23.00 (-0.48%)
Jun 19, 2025, 3:29 PM IST
Alkem Laboratories Revenue
In the fiscal year ending March 31, 2025, Alkem Laboratories had annual revenue of 129.65B INR with 2.34% growth. Alkem Laboratories had revenue of 31.44B in the quarter ending March 31, 2025, with 7.08% growth.
Revenue
129.65B
Revenue Growth
+2.34%
P/S Ratio
4.43
Revenue / Employee
7.44M
Employees
17,432
Market Cap
574.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 129.65B | 2.97B | 2.34% |
| Mar 31, 2024 | 126.68B | 10.68B | 9.21% |
| Mar 31, 2023 | 115.99B | 9.65B | 9.08% |
| Mar 31, 2022 | 106.34B | 17.69B | 19.96% |
| Mar 31, 2021 | 88.65B | 5.21B | 6.24% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Fortis Healthcare | 77.83B |
Alkem Laboratories News
- 15 days ago - Alkem Labs shares trade lower after Rs 856 crore block deal - Business Upturn
- 15 days ago - Alkem Labs in focus as promoter Jayanti Sinha to sell 1.42 percent stake via Rs 825 crore block deal - Business Upturn
- 20 days ago - Stocks to watch on May 30: Bajaj Auto, Ola Electric, Samvardhana Motherson, Suzlon, Alkem Labs in focus after key brokerage calls - Business Upturn
- 20 days ago - Nomura maintains ‘Buy’ on Alkem Labs; expects Semaglutide launch to drive future growth - Business Upturn
- 20 days ago - Jefferies maintains ‘Underperform’ on Alkem Labs and cuts target price to Rs 4,460 on margin concerns - Business Upturn
- 21 days ago - Stocks in focus on May 29: Bajaj Auto, Suzlon Energy, Alkem Labs, SJVN among 40 firms to report Q4 results - Business Upturn
- 3 months ago - Alkem Laboratories to acquire 100% stake in Bombay Ortho Industries - Business Upturn
- 3 months ago - Alkem Laboratories receives positive outcome from US FDA inspection at Taloja Bioequivalence Center - Business Upturn